SUNPHARMA.NS
Cash Flow
Sun Pharmaceutical Industries Ltd. · Healthcare
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-09-23 02:38
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹49.59 Bn | ₹121.35 Bn | ₹140.72 Bn | ₹124.19 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-79.44 Bn | ₹-6.90 Bn | ₹-53.06 Bn | ₹-113.44 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹23.76 Bn | ₹-67.10 Bn | ₹-79.06 Bn | ₹-25.13 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹7.24 Bn | ₹-0.73 Bn | ₹1.23 Bn | ₹9.39 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹1.15 Bn | ₹46.62 Bn | ₹9.83 Bn | ₹-4.98 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹45.08 Bn | ₹46.24 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
| Dividends Paid | ₹25.20 Bn | ₹29.01 Bn | ₹36.17 Bn | ₹39.38 Bn | DividendsPaidClassifiedAsFinancingActivities |
Every figure above is the exact value of the named XBRL element from SUNPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).